Alvotech (ALVO)
14.15
+0.50
(+3.66%)
USD |
NASDAQ |
Apr 26, 16:00
14.16
0.00 (0.00%)
After-Hours: 20:00
Alvotech Enterprise Value: 4.905B for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 4.905B |
| April 25, 2024 | 4.765B |
| April 24, 2024 | 4.734B |
| April 23, 2024 | 4.695B |
| April 22, 2024 | 4.676B |
| April 19, 2024 | 4.645B |
| April 18, 2024 | 4.553B |
| April 17, 2024 | 4.527B |
| April 16, 2024 | 4.508B |
| April 15, 2024 | 4.444B |
| April 12, 2024 | 4.371B |
| April 11, 2024 | 4.262B |
| April 10, 2024 | 4.270B |
| April 09, 2024 | 4.284B |
| April 08, 2024 | 4.307B |
| April 05, 2024 | 4.309B |
| April 04, 2024 | 4.212B |
| April 03, 2024 | 4.217B |
| April 02, 2024 | 4.136B |
| April 01, 2024 | 4.435B |
| March 28, 2024 | 4.365B |
| March 27, 2024 | 4.494B |
| March 26, 2024 | 4.444B |
| March 25, 2024 | 4.659B |
| March 22, 2024 | 5.129B |
| Date | Value |
|---|---|
| March 21, 2024 | 4.970B |
| March 20, 2024 | 5.013B |
| March 19, 2024 | 5.015B |
| March 18, 2024 | 4.959B |
| March 15, 2024 | 5.034B |
| March 14, 2024 | 5.039B |
| March 13, 2024 | 5.055B |
| March 12, 2024 | 5.037B |
| March 11, 2024 | 5.066B |
| March 08, 2024 | 5.111B |
| March 07, 2024 | 5.223B |
| March 06, 2024 | 5.213B |
| March 05, 2024 | 5.261B |
| March 04, 2024 | 5.218B |
| March 01, 2024 | 5.154B |
| February 29, 2024 | 5.055B |
| February 28, 2024 | 5.191B |
| February 27, 2024 | 5.296B |
| February 26, 2024 | 5.557B |
| February 23, 2024 | 5.226B |
| February 22, 2024 | 5.103B |
| February 21, 2024 | 5.151B |
| February 20, 2024 | 5.210B |
| February 16, 2024 | 5.170B |
| February 15, 2024 | 5.165B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.806B
Minimum
Jul 15 2022
5.557B
Maximum
Feb 26 2024
3.332B
Average
3.238B
Median
Sep 12 2023
Enterprise Value Benchmarks
| AbbVie Inc | 328.57B |
| Moolec Science SA | 60.48M |
| Teva Pharmaceutical Industries Ltd | 32.71B |
| Johnson & Johnson | 358.57B |
| Procaps Group SA | 570.84M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -276.56M |
| Revenue (Quarterly) | 53.39M |
| Total Expenses (Quarterly) | 130.54M |
| EPS Diluted (Quarterly) | -1.22 |
| Gross Profit Margin (Quarterly) | -5.67% |
| Profit Margin (Quarterly) | -518.0% |
| Earnings Yield | -17.17% |
| Normalized Earnings Yield | -13.00 |